Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Apogee Therapeutics Inc. (APGE) had Free Cash Flow per Share of $-0.91 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-55.34M |
|
-- |
|
-- |
|
$63.10M |
|
$-63.10M |
|
$7.84M |
|
$-55.26M |
|
$-55.26M |
|
$-55.34M |
|
$-55.34M |
|
$-55.34M |
|
$-55.34M |
|
$-63.10M |
|
$-65.27M |
|
58.20M |
|
58.20M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$521.53M |
|
$5.68M |
|
$192.63M |
|
$714.16M |
|
$32.96M |
|
-- |
|
$7.84M |
|
$40.80M |
|
$673.36M |
|
$673.36M |
|
$673.36M |
|
58.30M |
|
| Cash Flow Statement Financials | |
$-48.48M |
|
$12.98M |
|
$0.62M |
|
$142.08M |
|
$107.21M |
|
$-34.87M |
|
$11.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-52.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.22% |
|
-8.22% |
|
-7.75% |
|
-8.22% |
|
$11.55 |
|
|
Free Cash Flow per Share |
$-0.91 |
$-0.83 |
|